On March 10, 2022, the "People's Health Benefit Project" for early screening of colorectal cancer in Yinan County, sponsored by the Yinan County Health Bureau, was officially launched, with the participation of Lixin Nuokang (Shandong) Biomedical Technology Co., Ltd., a wholly-owned subsidiary of Lixin Biotechnology.

     At the launch ceremony, leaders of the Yinan County Health Bureau stated that the country is vigorously advocating for early screening, diagnosis, and treatment of cancer, with the aim of effectively improving people's health levels and truly achieving the grand goal of "Healthy China 2030".

      Taking this opportunity of the event, Liu Feng, General Manager of Lixin Nuokang (Shandong) Biomedical Technology Co., Ltd., introduced three early cancer screening and self testing products centered around the home digestive system, namely the multi gene mutation combined with DNA methylation early screening product "Lichangsheng", the home digestive tract occult blood self-test device "Changlexin" and "Changweile".

     Lixin Nuokang (Shandong) Biomedical Technology Co., Ltd. is a wholly-owned subsidiary and production base of Suzhou Linaxin Biotechnology Co., Ltd. The company is an advanced technology enterprise specializing in home health testing and early cancer screening; At present, it has passed the quality system certification of the Provincial Food and Drug Administration, obtained two national second-class medical device registration certificates, and obtained 6840 in vitro diagnostic and clinical testing device production licenses. It has a 3500 square meter GMP production base of 100000 and 10000 levels, five internationally advanced cancer early screening production lines, and a Binzhou Medical Inspection Center jointly built with Binzhou Xinyue Rehabilitation Hospital. The annual inspection and measurement can reach 500000 people. Currently, it has reached strategic cooperation agreements with multiple strategic partners for the year 2022.

     In addition, the company donated 3500 boxes of "Changle Xin" home fecal occult blood testing kits, and assisted township health centers and assisted village clinics in guiding rural community residents to use them. This supportive action effectively implements the spirit of relevant national documents, responds to the call of the county health bureau, and does what it can to improve the health level of the people in Yinan County. At the same time, it fully embodies the company's mission of "screening a sample early, saving a life, benefiting a family, and improving the health level of the people". With advanced technology and high-quality products, it bridges the last mile of health testing and cancer early screening, safeguarding the health of the people and striving to achieve the great dream of a Healthy China by 2030!